Detalles de la búsqueda
1.
Contaminated heparin associated with adverse clinical events and activation of the contact system.
N Engl J Med;
358(23): 2457-67, 2008 Jun 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-18434646
2.
Class modeling analysis of heparin 1H NMR spectral data using the soft independent modeling of class analogy and unequal class modeling techniques.
Anal Chem;
83(3): 1030-9, 2011 Feb 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-21192734
3.
Characterization of currently marketed heparin products: analysis of molecular weight and heparinase-I digest patterns.
Anal Bioanal Chem;
401(8): 2445-54, 2011 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-21901459
4.
Characterization of currently marketed heparin products: key tests for quality assurance.
Anal Bioanal Chem;
399(2): 581-91, 2011 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-20680615
5.
Determination of galactosamine impurities in heparin samples by multivariate regression analysis of their (1)H NMR spectra.
Anal Bioanal Chem;
399(2): 635-49, 2011 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-20953772
6.
Identification of heparin samples that contain impurities or contaminants by chemometric pattern recognition analysis of proton NMR spectral data.
Anal Bioanal Chem;
401(3): 939-55, 2011 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-21678118
7.
General Considerations for Diversifying Heparin Drug Products by Improving the Current Heparin Manufacturing Process and Reintroducing Bovine Sourced Heparin to the US Market.
Clin Appl Thromb Hemost;
27: 10760296211052293, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34894779
8.
Characterization of currently marketed heparin products: reversed-phase ion-pairing liquid chromatography mass spectrometry of heparin digests.
Anal Chem;
82(23): 9865-70, 2010 Dec 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-21069966
9.
USP compendial methods for analysis of heparin: chromatographic determination of molecular weight distributions for heparin sodium.
Anal Bioanal Chem;
406(20): 4815-23, 2014 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-24958344
10.
Pharmaceutical impurities: regulatory perspective for Abbreviated New Drug Applications.
Adv Drug Deliv Rev;
59(1): 64-72, 2007 Jan 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-17196703
11.
The US regulatory and pharmacopeia response to the global heparin contamination crisis.
Nat Biotechnol;
34(6): 625-30, 2016 06 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-27281424
12.
FDA Approval: Ibrutinib for Patients with Previously Treated Mantle Cell Lymphoma and Previously Treated Chronic Lymphocytic Leukemia.
Clin Cancer Res;
21(16): 3586-90, 2015 Aug 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-26275952
13.
FDA approval: ceritinib for the treatment of metastatic anaplastic lymphoma kinase-positive non-small cell lung cancer.
Clin Cancer Res;
21(11): 2436-9, 2015 Jun 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-25754348
14.
Radium Ra 223 dichloride injection: U.S. Food and Drug Administration drug approval summary.
Clin Cancer Res;
20(1): 9-14, 2014 Jan 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-24190979
15.
FDA approval: ado-trastuzumab emtansine for the treatment of patients with HER2-positive metastatic breast cancer.
Clin Cancer Res;
20(17): 4436-41, 2014 Sep 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-24879797
16.
Characterization of currently marketed heparin products: key tests for LMWH quality assurance.
J Pharm Biomed Anal;
85: 99-107, 2013 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-23917037
17.
Late recurrence of an ovarian yolk sac tumour as a carcinosarcoma.
Pathology;
39(6): 601-3, 2007 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-18027268
18.
Characterization of currently marketed heparin products: analysis of heparin digests by RPIP-UHPLC-QTOF-MS.
J Pharm Biomed Anal;
67-68: 42-50, 2012.
Artículo
en Inglés
| MEDLINE | ID: mdl-22633605
19.
Combining (1)H NMR spectroscopy and chemometrics to identify heparin samples that may possess dermatan sulfate (DS) impurities or oversulfated chondroitin sulfate (OSCS) contaminants.
J Pharm Biomed Anal;
54(5): 1020-9, 2011 Apr 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-21215547
20.
Oversulfated chondroitin sulfate is a contaminant in heparin associated with adverse clinical events.
Nat Biotechnol;
26(6): 669-75, 2008 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-18437154
Resultados
1 -
20
de 20
1
Próxima >
>>